Kyowa Kirin
Takashi Amano is a seasoned professional in the pharmaceutical industry, currently serving as the Head of Quality Compliance Department and Head of Regulatory Audit Department at Kyowa Kirin Co., Ltd. since June 2023. Prior to this, Takashi held the position of Senior Director, Head of Quality Assurance at Alinamin Pharmaceutical Co., Ltd. from January 2022 to May 2023, where responsibilities included managing Quality Assurance for medicinal products and foods in Japan and Asian markets. Takashi's extensive experience at Astellas Pharma from June 2008 to December 2021 encompassed various senior roles focused on product quality operations across international markets, compliance with Good Manufacturing and Distribution Practices (GMDP), and quality systems. Takashi began a career in Quality Control at Daiichi Sankyo, Inc., and holds a Bachelor's degree in Pharmaceutical Sciences from Tohoku University and an MBA from Arden University.
This person is not in any teams
This person is not in any offices
Kyowa Kirin
5 followers
Kyowa Hakko Kirin Co., Ltd. is mainly engaged in medical product and Biochemical businesses. The Medical Product segment is engaged in the manufacture, sale and sales promotion of ethical drug and reagent for clinical test, the development of candidate substances for new drugs, as well as the research and development of technologies for antibody drug creation, among others. It also involved in the contracting, retail and wholesale, and insurance agency businesses. The Biochemical segment manufactures and sells medical and industrial materials, mainly amino and nucleic acids, and healthcare products. This segment also designs and constructs facilities.